"First-line DMT discontinuation can lead to recurrence of inflammatory disease activity in approximately 20% of cases, even in patients with long-term stable MS," Strijbis and colleagues wrote.

They may experience symptoms, but their disabilities may not accumulate, and an MRI may not show an increase in disease activity. However, symptoms can worsen over time, and people with benign MS ...

They have a 20% chance of receiving an MS diagnosis in the same amount of time. RRMS is characterized by clearly defined relapses of increased disease activity and worsening symptoms. These are ...

Higher levels of the hormone also negatively correspond to MS activity in humans. In MS, the body’s immune cells attack the protective layer surrounding the neurons, leading to difficulties in muscle ...

Less frequent Ocrevus infusions are just as effective in controlling MS, but may help limit the risk of side effects, per a ...

MS is a disease that can affect your brain and spinal cord, and can cause problems with vision, balance, muscle control. As you learn more about they type of MS you have, you'll have a clearer ...

The mission of the UAB Multiple Sclerosis Center is to foster research, clinical and educational activities in the area of neuroimmunology with an emphasis on Multiple Sclerosis. The faculty and staff ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

MDedge News, September 26, 2024 ECTRIMS 2024 Genetic Depression Tied to Increased MS Disease Activity A higher cumulative genetic burden for depression is linked to an increased risk for relapse ...

Cladribine, a synthetic deoxyadenosine analog, is an oral immunomodulatory agent that produces targeted, sustained reduction of T and B lymphocytes. This mechanism of action provides the rationale ...